Symphogen symphogen.com

Symphogen is developing next-generation antibody therapeutics for the treatment of cancer and is dedicated to bringing truly innovative oncology products to the market. The company has advanced the frontier of antibody discovery by creating well-characterized antibody mixtures that address multiple oncology targets in a single drug product. The company has matured its pipeline, currently has two product candidates in the clinic, and is researching promising novel immuno-oncology opportunities.

Symphogen is developing next-generation antibody therapeutics for the treatment of cancer and is dedicated to bringing truly innovative oncology products to the market. The company has advanced the frontier of antibody discovery by creating well-char...Show all

See All Exits Recent Exits

Phone: +45 4526 5050

Fax:

Pederstrupvej 93

Ballerup, DK-2750
Denmark

Symphogen - Investments & Acquisitions

Show Real Data Symphogen Investments
See all Recent Investments
Date Company Round Amount Co-investors
2009-01-07Receptor BiologixAcquired
See all 1 investments